Prospeo
Hero Section BackgroundHero Section Background
Mediar Therapeutics

Mediar Therapeutics Revenue

Biotechnology ResearchFlag of US20 Overland St, Suite 520, United States51-100 Employees

$

Mediar Therapeutics revenue & valuation

Annual revenue$2,500,000
Revenue per employee$50,000
Estimated valuation?$8,000,000
Total funding$85,000,000

Key Contacts at Mediar Therapeutics

Flag of US

Aashna Gupta

Director, Human Resources

Flag of US

Adam Lindhorst

Director Of Accounting

Flag of US

Daniel Beal

Director, Clinical Program Lead

Flag of US

Karen Smith

Sr. Director, Program Management

Flag of US

Christopher Espelin

Sr. Director-Pharmacology And Translational Sciences

Flag of US

Vicki Kolb

Director, Clinical Site Liaison

Flag of US

Feny G.

Senior Director Of Cmc

Flag of US

Nick Messier

Associate Director Clinical Operations

Flag of US

Quinn Parks

Director, Clinical Supply Chain

Flag of US

Christopher Littlefield

Associate Director

Company overview

Headquarters20 Overland St, Suite 520, Boston, Massachusetts 02215, US
Phone number+16179360960
Website
NAICS541714
Founded2019
Employees51-100
Socials

Mediar Therapeutics Email Formats

Mediar Therapeutics uses 5 email formats. The most common is {first initial} (e.g., j@mediartx.com), used 46.4% of the time.

FormatExamplePercentage
{first initial}
j@mediartx.com
46.4%
{first initial}.{last name}
j.doe@mediartx.com
28.6%
{first name}.{last name}
john.doe@mediartx.com
14.3%
{first initial}{last name}
jdoe@mediartx.com
3.6%
{first name}
john@mediartx.com
3.6%

About Mediar Therapeutics

Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure. Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach. For more information, contact info@mediartx.com

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Director
Entry
Senior

Employees by Department

Mediar Therapeutics has 17 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Mediar Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-04-154$85,000,000

Funding Insights

$85,000,000

Total funding amount

$85,000,000

Most recent funding amount

1

Number of funding rounds

Mediar Therapeutics Tech Stack

Discover the technologies and tools that power Mediar Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Gravity Forms

Gravity Forms

Form builders

Slick

Slick

JavaScript libraries

PWA

PWA

Miscellaneous

jQuery UI

jQuery UI

JavaScript libraries

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

Cloudflare

Cloudflare

CDN

Twitter Emoji

Font scripts

Retina.js

Retina.js

JavaScript libraries

jQuery

jQuery

JavaScript libraries

PHP

PHP

Programming languages

WordPress

WordPress

Blogs

Frequently asked questions

Mediar Therapeutics is located in 20 Overland St, Suite 520, US.
You can reach Mediar Therapeutics at +16179360960.
Mediar Therapeutics generates an estimated annual revenue of $2,500,000. This revenue figure reflects the company's market position and business performance in its industry.
Mediar Therapeutics has an estimated valuation of $8,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Mediar Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.
Mediar Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.
Mediar Therapeutics has raised a total of $85,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles